These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31274700)

  • 1. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
    Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
    Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
    Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
    Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
    Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".
    Rakislova N; Clavero O; Alemany L; Saco A; Quirós B; Lloveras B; Alejo M; Pawlita M; Quint W; Del Pino M; de Sanjose S; Ordi J;
    Int J Cancer; 2017 Dec; 141(12):2517-2527. PubMed ID: 28815579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
    Yang H; Almadani N; Thompson EF; Tessier-Cloutier B; Chen J; Ho J; Senz J; McConechy MK; Chow C; Ta M; Cheng A; Karnezis A; Huvila J; McAlpine JN; Gilks B; Jamieson A; Hoang LN
    Mod Pathol; 2023 Jun; 36(6):100145. PubMed ID: 36828360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
    Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
    J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.
    Pouwer AW; Te Grootenhuis NC; Hinten F; de Bock GH; van der Zee AGJ; Melchers WJG; Oonk MHM; de Hullu JA; Hollema H; Bulten J
    Virchows Arch; 2024 Jun; 484(6):985-994. PubMed ID: 37938322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the Morphologic, Immunohistochemical, and HPV Genotypic Features of High-grade Squamous Intraepithelial Lesions of the Vulva With Morphology Mimicking Differentiated Vulvar Intraepithelial Neoplasia and/or Lichen Sclerosus.
    Griesinger LM; Walline H; Wang GY; Lorenzatti Hiles G; Welch KC; Haefner HK; Lieberman RW; Skala SL
    Int J Gynecol Pathol; 2021 May; 40(3):205-213. PubMed ID: 32925443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.
    Chaux A; Cubilla AL; Haffner MC; Lecksell KL; Sharma R; Burnett AL; Netto GJ
    Urol Oncol; 2014 Feb; 32(2):171-7. PubMed ID: 23499169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block.
    Wilson BL; Israel AK; Lott Limbach AA
    J Am Soc Cytopathol; 2021; 10(2):225-230. PubMed ID: 33092993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
    Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
    J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
    Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
    Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of p16 Immunohistochemistry and RNA In Situ Hybridization in the Classification of Adenoid Basal Tumors of the Cervix.
    Goyal A; Wang Z; Przybycin CG; Yang B
    Int J Gynecol Pathol; 2016 Jan; 35(1):82-91. PubMed ID: 26352551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential etiopathogenic features of vulvar squamous cell carcinomas in sub-Saharan Africa and Europe.
    Rakislova N; Carreras-Dieguez N; Manzotti C; Saúde O; Del Pino M; Chulo L; Rangeiro R; Lovane L; Lorenzoni C; Fernandes F; Rodrigo-Calvo MT; Diaz-Mercedes S; Ribera-Cortada I; Sanfeliu E; Del Campo RL; Marimon L; Alós S; Vega N; Pérez FM; Trias I; Carrilho C; Ordi J
    Int J Cancer; 2023 Feb; 152(3):496-503. PubMed ID: 36214794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.